DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees125
Employees125
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees125
Employees125
DBVT Key Statistics
Market cap761.29M
Market cap761.29M
Price-Earnings ratio-3.69
Price-Earnings ratio-3.69
Dividend yield—
Dividend yield—
Average volume147.72K
Average volume147.72K
High today$13.15
High today$13.15
Low today$11.81
Low today$11.81
Open price$13.04
Open price$13.04
Volume2.70M
Volume2.70M
52 Week high$26.19
52 Week high$26.19
52 Week low$8.86
52 Week low$8.86
DBVT News
Investing.com 1d
Cantor Fitzgerald reiterates DBV Technologies stock rating at overweight - Investing.com...
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
0%
Sell
11.1%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.